Helen M. Boudreau

Companies

• RallybioBoard member Jul 29, 2021 to now¹
• Shattuck Labs, Inc.Board member Oct 8, 2020 to now²
• Premier, Inc.Board member Jun 2, 2020 to now³
• Tvardi Therapeutics, Inc.Board member Aug 4, 2023 to Jun 6, 2024⁴
• Proteostasis Therapeutics (United States)Chief financial officer Aug 3, 2017 to Mar 5, 2018⁵
• Proteostasis Therapeutics (United States)Board member Feb 10, 2016 to Feb 12, 2016⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTvardi Therapeutics, Inc. TVRD150,647 shares⁷$149.7K at $0.99Jun 4, 2024
• Rallybio RLYB6,542 shares⁸$106.8K at $16.33Jul 6, 2026
• PPremier, Inc.0 shares⁹Nov 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 6, 2026Exercised options 3,562 shares at $2.38 of Rallybio⁸
• Nov 25, 2025Returned to company 18,668 shares at $28.25 of Premier, Inc.⁹
• May 30, 2025Sold 2,000 shares at $22.88 of Premier, Inc.¹⁰
• Jan 6, 2025Sold 2,500 shares at $21.42 of Premier, Inc.¹¹
• Dec 9, 2024Granted 7,101 shares of Premier, Inc.¹²
• Jun 4, 2024Granted 150,647 shares of Tvardi Therapeutics, Inc.⁷
• May 15, 2024Sold 6,629 shares at $19.85 of Premier, Inc.¹³
• Dec 4, 2023Granted 7,333 shares of Premier, Inc.¹⁴
• Dec 5, 2022Granted 4,636 shares of Premier, Inc.¹⁵
• Dec 6, 2021Granted 4,098 shares of Premier, Inc.¹⁶